Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

Brain

Volumn 137, Issue 5, 2014, Pages 1550-1561

  Mattsson, Niklas ^a,b,c   Tosun, Duygu ^a,c   Insel, Philip S ^a,c   Simonson, Alix ^a,c   Jack, Clifford R ^d   Beckett, Laurel A ^e   Donohue, Michael ^f   Jagust, William ^g   Schuff, Norbert ^a,c   Weiner, Michael W ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; beta amyloid; magnetic resonance imaging; perfusion imaging; PET imaging

Indexed keywords

AMYLOID BETA PROTEIN; FLORBETAPIR F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DISEASE COURSE; ENTORHINAL CORTEX; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; BETA-AMYLOID; MAGNETIC RESONANCE IMAGING; PERFUSION IMAGING; PET IMAGING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; CANADA; CEREBROVASCULAR CIRCULATION; DATABASES, FACTUAL; ETHYLENE GLYCOLS; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; SPIN LABELS; UNITED STATES;

EID: 84899789357     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu043     Document Type: Article

References (52)

1. Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, et al. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimers disease measured by pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci 2012; 262: 69-77.
2. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimers disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000; 47: 93-100.
3. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimers disease. Neuroimage 2008; 42: 1267-74.
4. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimers disease. J Alzheimers Dis 2010; 20: 871-80.
5. Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, et al. Amyloid load and cerebral atrophy in Alzheimers disease: an 11C-PIB positron emission tomography study. Ann Neurol 2006; 60: 145-7.
6. Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, et al. Effects of hypoperfusion in Alzheimers disease. J Alzheimers Dis 2011; 26 (Suppl 3): 123-33.
7. Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, et al. Assessment of Alzheimers disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis 2012; 31 (Suppl 3): S59-74.
8. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimers disease. N Engl J Med 2012; 367: 795-804.
9. Binnewijzend MAA, Kuijer JPA, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013; 267: 221-30.
10. Blennow K, de Leon MJ, Zetterberg H. Alzheimers disease. Lancet 2006; 368: 387-403.
11. Chao LL, Pa J, Duarte A, Schuff N, Weiner MW, Kramer JH, et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009; 23: 245-52.
12. Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 2010; 24: 19-27.
13. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimers disease? Neurology 2003 60 1374-7.
14. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, et al Relationship between atrophy and b-amyloid deposition in Alzheimer disease. Ann Neurol 2010 67 317-24.
15. Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 2009; 29: 14770-8.
16. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009; 250: 856-66.
17. Dashjamts T, Yoshiura T, Hiwatashi A, Yamashita K, Monji A, Ohyagi Y, et al. Simultaneous arterial spin labeling cerebral blood flow and morphological assessments for detection of Alzheimers disease. Acad Radiol 2011; 18: 1492-9.
18. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992; 23: 37-45.
19. Dougall NJ, Bruggink S, Ebmeier KP. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004; 12: 554-70.
20. Fink GR, Pawlik G, Stefan H, Pietrzyk U, Wienhard K, Heiss WD. Temporal lobe epilepsy: evidence for interictal uncoupling of blood flow and glucose metabolism in temporomesial structures. J Neurol Sci 1996; 137: 28-34.
21. Fleisher AS, Podraza KM, Bangen KJ, Taylor C, Sherzai A, Sidhar K, et al. Cerebral perfusion and oxygenation differences in Alzheimers disease risk. Neurobiol Aging 2009; 30: 1737-48.
22. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 1983; 7: 590-8.
23. Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, et al. Regional cerebral glucose transport and utilization in Alzheimers disease. Neurology 1989; 39: 1427-34.
24. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-6.
25. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Demonstration of decreased posterior cingulate perfusion in mild Alzheimers disease by means of H215O positron emission tomography. Eur J Nucleic Med 1997; 24: 670-3.
26. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimers disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013; 12: 207-16.
27. Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, et al. Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 2011; 68: 1526-35.
28. Jagust WJ, Mormino EC. Lifespan brain activity, b-amyloid, and Alzheimers disease. Trends Cogn Sci 2011; 15: 520-6.
29. Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimers disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol 1987; 44: 165-8.
30. Johnson NA, Jahng G-H, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005; 234: 851-9.
31. Kim SM, Kim MJ, Rhee HY, Ryu C-W, Kim EJ, Petersen ET, et al. Regional cerebral perfusion in patients with Alzheimers disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 2013; 55: 25-34.
32. Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 2012; 72: 578-86.
33. Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, et al. Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimers disease after 12-week donepezil treatment. Neuroimage 2012; 60: 1083-91.
34. Luh WM, Wong EC, Bandettini PA, Hyde JS. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999; 41: 1246-54.
35. Matsuda H. Role of Neuroimaging in Alzheimers Disease, with Emphasis on Brain Perfusion SPECT. J Nucleic Med 2007; 48: 1289-300.
36. Mosconi L, Tsui W-H, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD: automated FDGPET image analysis. Neurology 2005; 64: 1860-7.
37. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimers disease, and other dementias. J Nucleic Med 2008; 49: 390-8.
38. Oh H, Habeck C, Madison C, Jagust W. Covarying alterations in Ab deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp 2014; 35: 297-308.
39. Ossenkoppele R, Madison C, Oh H, Wirth M, van Berckel BNM, Jagust WJ. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? Cereb Cortex 2013.
40. Ossenkoopele et al. Cereb Cortex 2013, [Epub ahead of print], doi: 10.1093/cercor/bht076, First published online: March 28, 2013.
41. Raji CA, Lee C, Lopez OL, Tsay J, Boardman JF, Schwartz ED, et al. Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol 2010; 31: 847-55.
42. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimers disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-8.
43. Roberts DA, Detre JA, Bolinger L, Insko EK, Leigh JS Jr. Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. Proc Natl Acad Sci USA 1994; 91: 33-7.
44. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001; 22: 529-39.
45. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, et al. Cerebral blood flow in ischemic vascular dementia and Alzheimers disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 2009; 5: 454-62.
46. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001; 286: 2120-7.
47. Sojkova J, Beason-Held L, Zhou Y, An Y, Kraut MA, Ye W, et al. Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern? J Nucleic Med 2008; 49: 1465-71.
48. Tao R, Fletcher PT, Gerber S, Whitaker RT. A variational image-based approach to the correction of susceptibility artifacts in the alignment of diffusion weighted and structural MRI. Inf Process Med Imaging 2009; 21: 664-75.
49. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimers disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-80.
50. Wolk DA, Detre JA. Arterial spin labeling MRI: an emerging biomarker for Alzheimers disease and other neurodegenerative conditions. Curr Opin Neurol 2012; 25: 421-8.
51. Xu G, Antuono PG, Jones J, Xu Y, Wu G, Ward D, et al. Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology 2007; 69: 1650-56.
52. Yoshiura T, Hiwatashi A, Yamashita K, Ohyagi Y, Monji A, Takayama Y, et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 2009; 30: 1388-93.